Journal of Oncology

Table of Contents

  • Journal of Oncology -
  • Special Issue
  • Volume 2022
  • - Article ID 8281267
  • - Research Article

Deferoxamine Inhibits Acute Lymphoblastic Leukemia Progression through Repression of ROS/HIF-1α, Wnt/β-Catenin, and p38MAPK/ERK Pathways

Hongliang You | Dao Wang | ... | Yufeng Liu
  • Journal of Oncology -
  • Special Issue
  • - Volume 2022
  • - Article ID 3445350
  • - Research Article

IL-2 Modulates TAMs Derived Exosomal MiRNAs to Ameliorate Hepatocellular Carcinoma Development and Progression

Hao Chen | Chao Tang | ... | Yanqiang Huang
  • Journal of Oncology -
  • Special Issue
  • Volume 2022
  • - Article ID 8264059
  • - Research Article

The E3 Ubiquitin Ligase TRIM11 Facilitates Gastric Cancer Progression by Activating the Wnt/β-Catenin Pathway via Destabilizing Axin1 Protein

Ling Zhou | Heng Wang | ... | Ziling Fang
  • Journal of Oncology -
  • Special Issue
  • Volume 2022
  • - Article ID 8798306
  • - Research Article

Incidence and Durability of SARS-CoV-2 Antibodies in Patients with Cancer and Health Care Workers following the First Wave of the Pandemic

Catherine Lai | Arnold L. Potosky | ... | Michael B. Atkins
  • Journal of Oncology -
  • Special Issue
  • Volume 2022
  • - Article ID 8402568
  • - Research Article

Development and Validation of a Necroptosis-Related Prognostic Model in Head and Neck Squamous Cell Carcinoma

Zhijing Zhang | Xinglin Hu | ... | Lei Lei
  • Journal of Oncology -
  • Special Issue
  • Volume 2022
  • - Article ID 3449660
  • - Research Article

REchallenge of NIVOlumab (RENIVO) or Nivolumab-Ipilimumab in Metastatic Renal Cell Carcinoma: An Ambispective Multicenter Study

Charles Vauchier | Edouard Auclin | ... | Stéphane Oudard
  • Journal of Oncology -
  • Special Issue
  • - Volume 2022
  • - Article ID 1459636
  • - Research Article

Ai-Tong-An-Gao-Ji and Fisetin Inhibit Tumor Cell Growth in Rat CIBP Models by Inhibiting the AKT/HIF-1α Signaling Pathway

Jing Wang | Zonglang Lai | ... | Jun Cheng
  • Journal of Oncology -
  • Special Issue
  • - Volume 2022
  • - Article ID 4402536
  • - Research Article

EGFR-AS1 Promotes Nonsmall Cell Lung Cancer (NSCLC) Progression via Downregulating the miR-524-5p/DRAM1 Axis and Inhibiting Autophagic Lysosomal Degradation

Yang Xue | Jing Zhang | ... | Xin Wang
  • Journal of Oncology -
  • Special Issue
  • - Volume 2022
  • - Article ID 1183173
  • - Research Article

Development of a Novel Immune Subtyping System Expanded with Immune Landscape and an 11-Gene Signature for Predicting Prostate Cancer Survival

Nan Li | Kai Yu | ... | Dingyuan Zeng
  • Journal of Oncology -
  • Special Issue
  • - Volume 2022
  • - Article ID 6737248
  • - Research Article

Antitumor Effects of Natural Bioactive Ursolic Acid in Embryonic Cancer Stem Cells

Dong Young Kang | Nipin Sp | ... | Young Mok Yang
  • Journal of Oncology -
  • Special Issue
  • - Volume 2022
  • - Article ID 8423173
  • - Research Article

Pan-Cancer Analysis of Microfibrillar-Associated Protein 2 (MFAP2) Based on Bioinformatics and qPCR Verification

Zhilei Qiu | Miao Xin | ... | Zhijun Liu
  • Journal of Oncology -
  • Special Issue
  • Volume 2022
  • - Article ID 6497241
  • - Research Article

Comprehensive Pan-Cancer Analysis of IRAK Family Genes Identifies IRAK1 as a Novel Oncogene in Low-Grade Glioma

Jing Li | Yuchen Sun | ... | Xiaozhi Zhang
  • Journal of Oncology -
  • Special Issue
  • - Volume 2022
  • - Article ID 7467797
  • - Research Article

Signature of m5C-Related lncRNA for Prognostic Prediction and Immune Responses in Pancreatic Cancer

Xiangrong Liu | Dan Wang | ... | Xue Dong
  • Journal of Oncology -
  • Special Issue
  • - Volume 2022
  • - Article ID 2402212
  • - Research Article

MiR-526b-3p Inhibits the Resistance of Glioma Cells to Adriamycin by Targeting MAPRE1

Lei Qiu | Shuyuan Xing | ... | Qing Bao
  • Journal of Oncology -
  • Special Issue
  • - Volume 2022
  • - Article ID 8204818
  • - Research Article

Integrated Analysis of miR-7-5p-Related ceRNA Network Reveals Potential Biomarkers for the Clinical Outcome of Gastric Cancer

Meng-Yang Shi | Yan-fei Mu | Neng Shen
Journal of Oncology
 Journal metrics
See full report
Acceptance rate-
Submission to final decision-
Acceptance to publication-
CiteScore3.900
Journal Citation Indicator-
Impact Factor-

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.